Table 3.
Details and outcomes of patients with regional recurrence
Patient | Multifocality status | Histological details | Time to recurrence (years) | Level of recurrence | Management of recurrence | Final Outcome - ATA* response to treatment |
---|---|---|---|---|---|---|
1 | MFD† | Classical Variant, 1.3 cm, no VI§, mETE‖, negative margins | 1.2 | Ipsilateral Level 3 | CT¶ + MRND# | NED†† - Excellent |
2 | UFD‡ | Classical Variant, 1.4 cm, focal VI, no ETE, negative margins | 6.0 | Ipsilateral Level 2 | CT + MRND | NED – Indeterminate |
3 | MFD | Classical Variant, 0.8 cm, no VI, no ETE, positive margins | 10.6 | Contralateral Level 2,4 | CT + MRND | NED – Excellent |
4 | MFD | Follicular Variant, 1.8 cm, no VI, no ETE, positive margins | 11.3 | Contralateral Level 6 | CT + TEGD** | NED - Indeterminate |
5 | UFD | Classical Variant, 1.7 cm, no VI, no ETE, negative margins | 15.3 | Ipsilateral Level 4 | CT + MRND | NED - Unknown |
ATA – American Thyroid Association
MFD – multifocal disease
UFD – unifocal disease
VI – vascular invasion
mETE – microscopic extrathyroidal extension
CT – completion thyroidectomy
MRND – modified radical neck dissection
TEGD – tracheoesophageal groove dissection
NED – no evidence of disease